TipRanks
Integrated BioPharma Inc (INBP)
OTHER OTC:INBP
US Market
Want to see INBP full AI Analyst Report?

Integrated BioPharma (INBP) Financial Statements

10 Followers

Integrated BioPharma Financial Overview

Integrated BioPharma's market cap is currently $5.13M. The company's EPS TTM is $-0.0915; its P/E ratio is -1.86; Integrated BioPharma is scheduled to report earnings on September 25, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 26Jun 25Jun 24Jun 23Jun 22
Income Statement
Total Revenue$ 43.87M$ 54.35M$ 50.32M$ 50.67M$ 56.25M
Gross Profit$ 800.00K$ 5.56M$ 3.88M$ 4.06M$ 6.55M
Operating Income$ -2.71M$ 2.02M$ 251.00K$ 120.00K$ 1.97M
EBITDA$ -1.32M$ 3.38M$ 1.47M$ 1.27M$ 3.56M
Net Income$ -2.84M$ 808.00K$ 112.00K$ -34.00K$ 3.84M
Balance Sheet
Cash & Short-Term Investments$ 4.47M$ 3.62M$ 1.68M$ 1.32M$ 331.00K
Total Assets$ 25.34M$ 24.90M$ 26.21M$ 25.43M$ 25.25M
Total Debt$ 3.08M$ 1.01M$ 1.80M$ 2.67M$ 2.06M
Net Debt$ -1.39M$ -2.60M$ 121.00K$ 1.36M$ 1.72M
Total Liabilities$ 7.67M$ 4.58M$ 6.97M$ 6.57M$ 6.67M
Stockholders' Equity$ 17.67M$ 20.32M$ 19.24M$ 18.86M$ 18.57M
Cash Flow
Free Cash Flow$ 895.00K$ 1.87M$ 390.00K$ 1.12M$ 3.60M
Operating Cash Flow$ 1.24M$ 2.06M$ 943.00K$ 1.23M$ 4.09M
Investing Cash Flow$ -340.00K$ -205.00K$ -553.00K$ -111.00K$ -465.00K
Financing Cash Flow$ -45.00K$ 78.00K$ -29.00K$ -136.00K$ -3.50M
Currency in USD

Integrated BioPharma Earnings and Revenue History

Integrated BioPharma Debt to Assets

Integrated BioPharma Cash Flow

Integrated BioPharma Forecast EPS vs Actual EPS